C1QBP and neoplasm: Moreover, another tumor-homing peptide, LyP-1 (CGNKRTRGC), capable of targeting the cell surface of localized C1QBP, has been used to deliver nanoparticles to breast tumors overexpressing C1QBP and has shown efficacy in vivo (Luo et al., 2010).